Frank Mottola - Feb 16, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role: SVP, Quality, GMP, Ops, IT
Signature: /s/ Timothy C. Dec, as attorney-in-fact
Stock symbol: SUPN
Transactions as of: Feb 16, 2023
Transactions value $: -$29,171
Form type: 4
Date filed: 2/21/2023, 04:35 PM
Previous filing: Jan 17, 2023
Next filing: Apr 12, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	SUPN	Common Stock	Options Exercise	$0	+1.5K	+20.15%	$0.00	8.94K	Feb 16, 2023	Direct	F1
transaction	SUPN	Common Stock	Tax liability	-$29.2K	-753	-8.42%	$38.74	8.19K	Feb 16, 2023	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	SUPN	Performance Share Unit	Options Exercise	$0	-1.5K	-100%	$0.00^*	0	Feb 16, 2023	Common Stock	1.5K	$0.00	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Shares of common stock received upon the settlement of certain performance share units granted to the Reporting Person on April 30, 2021.
F2	On April 30 2021, the Reporting Person was awarded Performance Share Units a portion of which vested upon the achievement of individual performance objectives within a defined performance period.